An Impressive Approach in Nuclear Medicine
| Autor: | Hojjat Ahmadzadehfar, Nasim Vahidfar, Anna Yordanova, Saeed Farzanehfar, Elisabeth Eppard, Maryam Fallahpoor |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Radiation
Somatostatin receptor business.industry General Medicine Neuroendocrine tumors medicine.disease 030218 nuclear medicine & medical imaging 03 medical and health sciences Prostate cancer 0302 clinical medicine 030220 oncology & carcinogenesis Radionuclide therapy medicine Radioligand Radiology Nuclear Medicine and imaging business Nuclear medicine Membrane antigen |
| Zdroj: | PET Clinics. 16:327-340 |
| ISSN: | 1556-8598 |
| DOI: | 10.1016/j.cpet.2021.03.011 |
| Popis: | Radiometal-based theranostics or theragnostics, first used in the early 2000s, is the combined application of diagnostic and therapeutic agents that target the same molecule, and represents a considerable advancement in nuclear medicine. One of the promising fields related to theranostics is radioligand therapy. For instance, the concepts of targeting the prostate-specific membrane antigen (PSMA) for imaging and therapy in prostate cancer, or somatostatin receptor targeted imaging and therapy in neuroendocrine tumors (NETs) are part of the field of theranostics. Combining targeted imaging and therapy can improve prognostication, therapeutic decision-making, and monitoring of the therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|